Summary: Despite cautious and limited guideline endorsement, beta blockers are widely used in cardiovascular disease (and beyond). Why? Our guest Dr Sripal Bangalore discusses his research, which caused a stir in CV spheres but actually does not differ greatly from the guidelines. What is the evidence for beta blockers in CV disease? What are the next steps for this research?
